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THE EFFECTS OF PARKINSON'S ON FlXATlONAL STABILITY 
By Erin L. Mallahan, MS .  
A Thesis submitted in partial fulfillment of the requirements for the degree of 
Master of Science at Virginia Commonwealth University. 
Virginia Commonwealth University, 2005 
Major Director: Dr. Paul A. Wetzel 
Associate Professor, Department of Biomedical Engineering 
Parkinson's disease (PD) is a progressive, neurological movement 
disorder. The stability of eye movements in PD is not well understood but many 
patients report difficulty doing tasks that require stabilized fixation and gaze. The 
ability to stabilize an image on the retina is critical is acquiring visual information. 
The purpose of this study was to compare the stability of fixational eye 
movements of PD patients to those of age-matched controls. Eye movements 
during simple fixation tasks were recorded from 66 subjects (ages 52 to 84), and 
36 age-matched controls (ages 58-85). The absolute velocity of the fixational 
eye movements were recorded and correlated to a clinical measure of disease 
. . . 
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progression as measured by the Unified Parkinson's Disease Rating Scale 
(UPDRS). Unstable, non-rhythmic eye movements were seen in the PD patients. 
There were significant differences in the absolute velocity and standard deviation 
between the control group and the PD group in both the horizontal and vertical 
directions. The correlation of the absolute velocity to the UPDRS was not 
significant. Parkinson's disease does appear to affect the stability of eye 
movements. The instabilities in the eye movements appear to precede body 
tremor. This could lead to an early method for diagnosis and analysis of the 
disease. 
CHAPTER 1 Introduction 
Parkinson's Disease 
Parkinson's disease (PD) is a progressive neurodegenerative disorder, 
first described in 181 7 by James Parkinson, that involves a decreased level of 
dopamine. Dopamine is a neurotransmitter that is produced in the brain and 
controls movement and coordination. With PD, a person's dopamine production 
levels begin to decrease. This is followed by the death of the cells in the brain 
that produce dopamine.['] While the cause of PD is not known, some of the 
physiological changes .that occur are known. One relationship affected by a 
decrease in dopamine is the one between dopamine and acetylcholine. This is 
normally an antagonistic relationship in which neurons are inhibiting and exciting 
to regulate movement. The decrease in dopamine results in uncontrolled 
excitatory impulses, which causes an imbalance of the motor systems.[*] 
There are several areas of the brain that PD is thought to affect, but the 
most common is the substantia nigra. The substantia nigra is a nucleus located 
in the midbrain, and is divided into two parts; ,the pars re.ticulate (SNr) and the 
pars compacta (SNc). Nerve cells in the SNr send dopamine to both sides of the 
brain.[31 There is also pathological evidence of degeneration of melanin- 
containing cells in the SNc. This is caused by the decrease in dopamine, as 
melanin is a by-product of dopamine synthesis ['I. 
1 
The substantia nigra is functionally related to the basal ganglia [411 which 
are cell groups within the cerebral hemisphere15]. The basal ganglia modulate 
signals that originate in the cerebral cortex to direct individual muscles during 
voluntary movement. Damage to the basal ganglia can result in a disruption of 
these movements. Common symptoms of basal ganglia-related disorders, 
akinesia and bradykinesia, are also common symptoms of PD. The primary 
symptoms of PD are resting tremor, rigidity, akinesia, bradykinesia, and postural 
instability. 
Akinesia describes a problem initiating movement. S'tudies in nonhuman 
primates showed that basal ganglia are most active in the planning phase of 
movement [51. Therefore, akinesia is an outward sign of the disruption in the 
basal ganlia's role in the planning and generation of programmed movement. 
Bradykinesia describes the slowing of movement [61J and is seen as a reduction in 
velocity and amplitude of movement 15]. Although the resting tremor is a 
commonly recognizable symptom, other symptoms of the disease can be more 
debilitating for the patients. PD symptoms usually begin unilaterally, and can 
progress to affecting both sides. Parkinson's is diagnosed by identifying some of 
these characteristic symptoms. 
There are several clinical measures used to quantify these symptoms. 
These measures are generally subjective, thereby showing limitations of the 
currently used scales. A more objective way of measuring the progression of the 
disease could be a major asset to the study of this disease. The Unified 
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Parkinson's Disease Rating Scale (UPDRS) is one of the most widely used 
clinical measures. This scale was developed by incorporating parts from the 
multiple scales that were previously being used. The goal of the UPDRS was to 
provide a comprehensive way for clinicians to monitor disabilities and 
impairments caused by PD. It is broken into four sections: Behavior and Mood, 
Activities of Daily Living, Motor, and Complications. The UPDRS is currently the 
most commonly used PD assessment scale, and is also widely used throughout 
the world. It is commonly used as a reference in studies rating specific aspects 
of PD.['] UPDRS scores for the Motor section (Ill) can range from 0 to 108. The 
scores are determined by a clinician by answering a series of questions and 
assigning a value of 0-4 for each question, with 0 being no disability and 4 being 
severe disability. The motor section of the UPDRS covers questions on speech, 
facial expression, resting tremor, postural tremor, rigidity, finger taps, hand 
movements, rapidly alternating pronation and supination of hands, leg agility, 
ability to arise from chair, posture, gait, postural stability, and body 
bradykinesiaL8]. It can then be seen, that this clinical scale does not address 
visual problems. 
The next most widely used rating scale for Parkinson's disease is the 
Hoehn and Yahr (HY) staging scale. The scale uses stages (1-5) to evaluate 
disease severity. It is over 30 years old, but was modified in the 1990s to include 
0.5 increments. The stages range from unilateral impairment (Stage 1) to 
bilateral impairment, postural instabilities, loss of physical independence, and 
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being wheelchair or bed-bound (Stage 5). Although the HY scale accounts for 
some of the major aspects of the progression of PD, it has several limitations. 
The stages are limited in number and are non-linear. The scale, which weighs 
postural instability as a major gauge of PD progression, does not give much 
weight to other motor factors and does not give any consideration to non-motor 
aspects of PD. Ig1 
Although the cause of PD is not yet known, there are factors that have 
been determined that play a role. The role of genetics does not appear to be 
significant, although there have been reports of people within a family suffering 
from PD. Some genes have been found defective in some of these people, but 
the majority of PD cases are still random.[101 Besides genetic factors, 
environmental factors such as place of residence, source of drinking water, and 
occupational or residential exposure to industrial chemicals and processes are 
also thought to play a role in PD["]. Research has yet to determine what is 
causing the cell death leading to PD, but some theories that have arisen are free 
radicals, prompted by oxidation, cause cell death. Others suggest that there is 
some dysfunction of mitochondria while others think that excitotoxicity, when 
neurotransmitters become unbalanced, may be the cause. Most researchers 
believe the cause is a combined effect of genetic, environmental, and biological 
factors. [lo] 
Parkinson's disease affects both men and women and can be found in all 
ethnic, economic, and geographical groups. While as many as half of the cases 
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in the US may be undiagnosed, it is estimated that 1.5 million people in the US 
suffer from PD, with 60,000 new cases being diagnosed each year. Although 
some patients are diagnosed earlier, onset is usually after age 60. ['*I A study by 
Van Den Eeden, et al. studied 588 newly diagnosed cases of PD in a northern 
California clinic to determine incidence rates for age, race, and gender. The 
study showed the male to female ratio of incidence to be 1.9:1. The incidence 
rates for both males and females rose rapidly after the age of 60. The study 
found only 4% of the patients were under the age of 50. The male to female ratio 
was approximately 2.0:1 in all racial groups (non-Hispanic white, Hispanic, Black, 
and Asian) except Asians, where the incidence of PD was slightly higher in 
females. [I3] The reason for this irregularity is not known, however it is suggested 
that perhaps it is due to environmental factors. 
There are now several treatments available for patients with PD. It is 
important to know that these treatments help lessen symptoms, but there is 
currently no cure for this disease. Treatment can include the use of 
pharmacological treatment, surgery, or a combination of both. The most 
commonly used pharmacological treatment is levodopa (L-dopa). It first became 
available is the 1960's-1970's. It is initially very effective in reducing symptoms, 
but the effectiveness diminishes and the side effects can be debilitating [ I 4 ] .  
There are also several kinds of surgeries that patients may receive. 
Ablative surgeries were the common way of treating Parkinson's beginning in the 
1950s. When drugs like L-dopa were discovered, surgeries became less often 
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used. When the effects of the drug became more prevalent, surgeries became 
popular again. Ablative surgeries, like thalamotomies and pallidotomies use 
electrodes to destroy cells in the brain that are overactive in PD patients. In the 
mid-1 990s a non-ablative surgery was discovered. 
Deep brain stimulation (DBS) involves implanting a small lead into the 
thalamus and connecting it to a small pacemaker-like device. On the end of the 
lead is a multi-site stimulating electrode. This technique does not destroy cells; it 
temporarily disables them by firing rapid pulses of current [I5]. This technique has 
become very popular in the last few years because it has several advantages 
over ablative surgeries and because it has had very promising results. DBS is 
reversible, and can be adjusted to obtain maximal benefits. It can also be 
performed on both sides of the brain, while the risks of cognitive or neurological 
deficits are too high to have bilateral ablative surgery [I6]. There are current 
studies to determine the best place to implant the lead. There are several areas 
in the brain that are currently used, including the globus pallidus internus (GPi), 
the subthalamic nucleus (STN), and the ventral intermediate nucleus (VIM) of the 
thalamus. VIM stimulation treats tremor well but not the other symptoms of the 
disease. GPi stimulation and STN stimulation are thought to treat all of the major 
symptoms [141. 
Oculomotor System 
Parkinson's disease is often thought of as a neurological disease that 
affects the motor system, and the visual effects are often overlooked. However, 
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about 40% of the fibers in the brain carry "information related to visual 
so some type of visual dysfunction often occurs with damage to the brain. The 
oculomotor system is very complex and involves coordination from various 
aspects of the system. The saccadic system controls foveation, and the pursuit 
system tries to match the eye's velocity to that of the moving target's. ["I 
The fovea is the part of the retina with the greatest visual acuity. While 
the region of the fovea covers a visual angle of about 2") the greatest acuity is 
found in a 0.8" area of the fovea[18]. The eyes move allowing the target to fall on 
the fovea for maximum acuity [lgl. The stabilization of this stationary target on the 
fovea is described as fixation. If the movement of the image on the retina 
exceeds 4°/sec[201211 , vision is degraded. The length of a fixation varies with 
task. A typical fixation during silent reading lasts at least 200ms, while a typical 
fixation during typing lasts about 400ms [201. During fixation the eye is relatively 
stable while information is being extracted, however, there are very small eye 
movements occurring during fixation. 
- I Fixation * 
22' 
0 . - 
Y 
Figure 1: Example of a Typical 
Fixation 
Fixation 
0 1 2 3 4 5 6 7 8  
Time (sec) 
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Tremor is a high frequency movement, typically from 30-1 00Hz with an 
amplitude of 5 to 30-sec arc, and is not correlated between the two eyes. Drift, 
which is also not correlated between the two eyes, is a low-velocity movement 
with an amplitude of 1 to 5-min arc, with irregular movement and frequency. 
f 
Microsaccades occur once or twice each second, with an amplitude of 5-min arc. 
Microsaccades are highly correlated between the two eyes. [17,19,20,221 sometimes 
abnormal fixations occur resulting from slow drift, saccadic intrusion, or 
nystagmus, an involuntary rhythmic oscillation of the eye [Ig1. 
Saccadic eye movements are voluntary movements used to move the eye 
from one position to another without following an object between the two points. 
They consist of high-velocity, accurate eye movements that foveate on the 
intended object. They are generated by a high frequency neural pulse that move 
the eye to a new position quickly, and a tonic step that maintains the eyes in the 
new position. The reaction time of the saccadic system, which refers to the time 
between the target's movement onset and the onset of the saccade, is about 200 
ms. Sometimes, abnormalities can be found in the saccadic system. Slowed 
dynamics is when the peak velocity is slower than normal. The duration of the 
saccade can also be longer during slowed dynamics. There can also be 
inaccurate amplitude, when the number of dysmetric saccades increases. This 
creates the need for more corrective saccades. This abnormality is sometimes 
seen in PD patients. The third abnormality is delayed initiation, in which there is 
an abnormally long reaction time.[''] The occurance of this abnormality increases 
with age. 
The pursuit system, a continuous system that is not under voluntary 
control, is in control of the smooth movement tracking of objects. The pursuit 
system does this by matching the eye velocity to the velocity of the moving 
target. Because the eyes are foveated on the object for sustained times, there is 
better resolution and more gathering of information. If there is an error in 
positioning of the pursuit system, it is corrected with a saccade. The pursuit 
system has a latency of 100ms. [ I7 ]  
Normal activities in which the head moves could potentially cause 
smearing of images on the retina. Two systems prevent this from happening. 
The vestibular system compensates for brief head movements, and the 
optokinetic system compensates for prolonged head movements. These two 
systems work together to allow head and body movements without affecting the 
visual system. The vestibular system is important for maintaining overall body 
posture, equilibrium, and muscle tone, but it is also important in maintaining the 
stability of images on the retina during brief head movements. It does this by 
producing eye movements that compensate for the head movements. [ I7 ]  The 
compensatory system is critical in maintaining a stable gaze during normal 
movements. 
One of the most complex tasks involving eye movements is reading. 
Reading involves many systems of the body working together because there is a 
large cognitive element as well as an oculomotor element. The typical reading 
10 
pattern resembles a staircase, as seen in Figure 2'331 below. The reading pattern 
of a PD patient can vary greatly from this predictable pattern. The pattern is less 
stable and tremor can be seen (Figure 3[351). If PD is shown to affect the eye's 
ability to stabilize an image or if it affects the ability to have a stable gaze, the 
ability to acquire the visual image can be lessened. 
Horizontal Eye - 
- - -- 
Position - . 
-- - Return Sweep _- 
I -- 
Fixation -- - 
,I. - ' Regression 
--- 
- -___ - I- - <-- -- - -. - _ - 
Vertical Eye Position --- --____ 
Figure 2: Normal eye movement recording while reading 
I Unstable Fixation I 
/-- I -- Return Sweep +-. Horizontal Gaze / -- - ,- 
-r -.d - 
%- - - - -. .- 
A 
7 2--" 
---- b .  -- / Regression 
-4 .-- 
Vertical Gaze 
8s Recort 
Figure 3: Eye movement recording while reading for a PD patient 
Aqinq and the Visual System 
Aging has been found to affect the visual system in several ways. While 
the fixational eye movement system does not show significant changes in 
stability due to aging, the range of fixation does decrease with age. For example, 
.the maximal limits of the field of fixation during adduction decrease from 57 
degrees for 20-29 year olds to 54 degrees for ages 50 and older[17]. Beginning 
around age 40, the lens begins to lose its elasticity and becomes more flattened 
in its relaxed state. Because the lens focuses light on the retina, this change in 
shape affects a person's ability to accommodate. [51 Aging has also been shown 
to affect the saccadic system. The reaction time increases with age at a rate of 1 
to 2 ms per year. The peak velocity of the saccades decrease with age, but the 
accuracy of the saccades has not been found to decrease with age [I7]. Affects 
of aging can also be seen in the pursuit system. There is a decrease in the gain, 
and increase in saccades, and a decreased initial acceleration, which can 
decrease by 30% [I7]. The increase in saccadic activity is caused by an increase 
in positioning errors, which are corrected by saccades. There can also be an 
increase in the velocity latency, but no change has been seen in the acceleration 
latency [I7]. 
Parkinson's Disease and the Visual System 
Parkinson's disease has been shown to have an effect on the visual 
system. Many PD patients complain of visual problems, but these complaints 
may be overlooked as age-related complications or less important than the other 
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symptoms of PD. However, more research is being done on the effects of PD on 
the visual system. These effects however, can lead to drastic declines in 
patients' quality of life, including problems with reading, driving, watching 
television, and other daily activities. One explanation for the effect of PD on the 
visual system is that the basal ganglia are affected in PD. This area of the brain 
is related to eye movements, including saccadic activity. Lesions to the basal 
ganglia can result in impaired stimulus-response reactions [231. 
There are known effects of Parkinson's disease on the visual system. 
Common abnormalities include hypometric saccades and impaired smooth 
pursuit [241 251181. Steady fixation has been found to be interrupted by saccadic 
intrusion[261, where the eyes make saccades instead of maintaining fixation[181. 
Upward gaze has also been found to be restricted in PD pa.tients[271, but this is 
also observed in normal elderly patients[281. Corin et al. [271 reported oculomotor 
abnormalities in three quarters of their PD patients. In visually guided tasks, 
advanced PD patients showed prolonged mean latencies [291. Manual tracking in 
PD patients have shown slowed movements and poor sinusoidal tracking as well 
as a significant reduction in saccadic accuracy [241. Along with reduced saccadic 
accuracy, slowed saccadic initiation can be seen [30,24129,251. It appears that the 
akinesia that is a major symptom of PD can also be seen it the oculomotor 
system of patients with mild, untreated PD [241. 
Chan et al. [311 studied 18 PD patients and 18 controls to determine 
effects of PD on the saccadic system. They found that there were characteristics 
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of saccadic eye movements that were affected by PD. The subjects were 
instructed, among other tasks, to look toward a peripheral stimulus as soon as it 
appeared. The PD patients were found to make more express saccades in this 
task than the control group, showing that they have deficits in their ability to 
inhibit automatic saccades. The author suggests that these results are 
consistent with a disorder of the prefrontal basal ganglia circuit. [311 Another 
study found that the amplitude of saccades increased ninety minutes following a 
dose of L-dopa, showing that there may be a correlation between dopamine and 
control of some ocular movements. There have also been studies to examine 
the effects of dopamine loss in the retina. The levels of dopamine in the retinas 
of patients with PD were less than the controls. This may show that the loss of 
dopamine in the retina and some areas of the brain associated with the visual 
system may be the cause of visual problems in PD patients. [21 
These studies are beginning to show the effects of PD on everyday 
visually related tasks. Balance, which is also affected by PD, can play a role in 
visual problemsw. As stated above, reading is a very complex task that involves 
several systems within the body. Fundamental to reading is the ability to 
stabilize fixation and gaze. These studies may help to explain the difficulty for 
PD patients to read. 
Objective 
The ability to fixate and control eye moments is fundamental for the 
extraction of visual information. The objective of this study is to determine the 
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effects of PD on the stability of fixational eye movements. The goals of this study 
are to determine the effects of PD and treatments on eye movements, to 
compare data with those of age-matched controls, and to correlate the data with 
curren,tly used clinical measures of PD. While there have been numerous 
studies on the effects of PD on the saccadic system and on the pursuit system, 
the effects of the disease on fixation has been overlooked. Studying fixation is 
important because the ability to stabilize fixation is critical in obtaining visual 
information. It is important for the general health community to understand these 
effects of the disease and how they affect patients' quality of life. 
CHAPTER 2 Methods 
Subjects 
The subjects who participated in this study were recruited from Virginia's 
Commonwealth University's Ambulatory Care Center (ACC) clinic as well as the 
Parkinson's Disease Research, Education, and Clinical Center (PADRECC) at 
the Hunter Holmes McGuire Veterans Affairs Medical Center (VA). The 66 
subjects ranged in age from 52 to 84 years, with the average age 71.5 years, and 
are comprised of 50 males and 16 females. Nineteen males and 14 females 
comprised the 33 PD patients from the ACC, and 31 males and 2 females 
comprised the 33 PD patients from the PADRECC. Spouses or friends 
accompanying patients to the clinics were used as age-matched controls. The 
importance of the age-matched controls is to have a basis of comparison for age- 
related affects on the visual system. There were 36 controls, 6 males and 30 
females, ranging in age from 58 to 85 years, with the average age 71.7 years. 
Three males and 8 females comprised the 11 controls from the ACC, and 3 
males and 22 females comprised .the 25 controls from the PADRECC. 
The recruitment and testing of all subjects and controls were conducted 
under protocol approved by both VCU's and the VA's IRB. Subjects were 
informed of the procedures before beginning and all subjects, patients and 
controls, gave informed consent about participating in the study. Patients were 
15 
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tested immediately before or following their scheduled clinical appointment in 
which they where evaluated and given a clinical measure of disease severity 
based on the motor section of the Unified Parkinson's Disease Rating Score 
(UPDRS). Clinicians had the option of excluding patients who, due to cognitive 
abilities could not give informed consent. 
Apparatus and Setup 
Horizontal and vertical eye movements of the right eye were recorded 
using a pupil cornea, head-mounted eye tracking system (Vision 2000, El Mar, 
Inc., Toronto, Canada). The non-collimated infrared beams, pulsed at 120 Hz, 
illuminate the subject's eyes while sensors detect the two corneal reflections 
(Figure 4). Because the infrared beams are non-collimated, the pupil remains 
dark. A beam-splitter redirects the reflected infrared light from the eye to a two- 
dimensional charge coupled device (CCD) array located above the eye.[321 The 
image of the eye as well as the corneal reflection are viewed on a small video 
monitor, allowing adjustment of infrared intensity for maximum contrast. The 2D 
CCD array measures the intensity of the infrared light reflected from the eye 
along the rows and columns, and maps it to a three-dimensional topographical 
map, where the corneal reflections appear as peaks and the pupil appears as a 
sink hole. The image of the eye is then fitted to an ellipsoid and an algorithm is 
used to estimate the pupillary center using the corneal reflections (Figure 5) .  The 
algorithm estimates the center of the pupil using the known op,tical center and the 
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estimated visual center. This information produces a signal that is sent to a 
corr~puter for processing and viewing. 
Figure 413": Estimate of pupil center and 
corneal reflections 
DARK 
PURL 
CORtL 
REFLEIXW 
Figure 5[321: Mapping of image onto 2D CCD 
array 
The head-mounted portion of the eye tracker weighs less than 300 grams 
and has a measurement range is ~ 4 5 "  horizontally and ~ 3 5 "  vertically. The 
vertical range can be less due to occlusions such as the lids or lashes. The 
resolution is better than 0.2".[~*] A six-degree-of-freedom, magnetic, head- 
tracking device (Flock of Birds, Ascension Technologies, Burlington, VT) was 
attached to the top of the eye tracker, and the transmitter was located close to 
the back of the head to minimize non-linearities and distortions. The head 
tracker provides x, y, and z positions as well of yaw, pitch, and roll angles. 
Figure 6[351: Eye and Head tracking system 
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The eye and head tracking systems both sample and output data at a rate 
of 120 Hz. The serial outputs of each system were linked to a ToshibaTM 
notebook computer through two USB-to-serial port converters (IOGEAR Model 
GUC232A). The serial interface port and experimental control program that was 
used to communicate with both trackers was developed by Dr. Paul A. Wetzel. 
The serial port on the eye tracker ran at 38k baud, and the head tracker at 115k 
baud. The head tracker runs at a higher rate to accommodate the large amount 
of data it is sampling because of the six degrees-of-freedom. 
Experimental Procedures 
The fixation target board is a flat black board with yellow target dots 
located at 0, + 5", and + 10" in both the horizontal and vertical directions (see 
Figure 7). The target board is located on a laboratory jack, enabling it to be 
adjusted for each subject so the horizontal axis was lined up with their eyes. 
Each subject was seated at a table in a lighted room. The eye-head tracking 
system was put on each subject's head, and they were told that they should 
move their head and eyes normally. The system allows the subjects to move 
freely, with limited restrictions. The band is adjustable so the system fits snuggly 
on the subject's head. The eye can be viewed on a small video monitor, allowing 
for adjustments for position and focus. The intensity of ,the infrared beams is also 
adjusted to obtain ideal contrast. 
The device is calibrated for each subject before the testing begins. This 
process takes less than one minute and is done by having the subject look at the 
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target dots on the fixation target board in an order preprogrammed within the 
system. After calibration, the subjects, seated one meter from the center of the 
fixation target board, were verbally instructed to fixate on the target dots located 
on the fixation target board. The test lasted about 2 minutes for a quick 
assessment so as not to fatigue the subjects. Subjects were also given smooth 
pursuit and compensatory tasks. This data was observed to verify the behavior 
of the compensatory system was working, but was not analyzed. 
Figure 713": Experimental Setup 
A difficulty sometimes arises in collecting data because many of the 
patients wear glasses andlor have ptosis. While the system can be used with 
glasses, the data obtained is not always usable. Interference from the eyelids 
occluding the majority of the pupil can make it impossible for the eye tracker to 
be calibrated because it is dependent on the view of the pupil. If a subject wore 
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glasses, the system was adjusted so that they could complete the experiment 
with the glasses on. This is accomplished by reducing the glare of the infrared 
light onto the lenses of the glasses by angling away from the beam-splitter so 
that they do not interfere with the corneal reflections. Four of the subjects (2 PD 
patients and 2 controls) did not have usable data due to either problems during 
calibration or the data was too chaotic to be usable. 
Data Analvsis 
The data is complied, and the recordings are converted to binary VfPlot 
files and saved in a sequential format. These files are then parsed into individual 
horizontal, vertical, pupillary, x, y, z, yaw, pitch, and roll files. These recordings 
can then be viewed in the VfPlot program (written by Dr. Paul A. Wetzel) as head 
and eye movements. Cursors are used to obtain information from the plots such 
as position, velocity, and absolute velocity measurements, as well as their 
standard deviations. The cursors are manually placed at the beginning and end 
of each fixation. All possible fixations had to meet certain criteria to be counted 
as a fixation. They had to be greater than 125 ms to be considered and 
measured as a fixation. This value was constant for all data analyzed, and was 
decided based on standard fixation lengths while also considering standard 
deviations of fixation lengths and effects of age or disease. Corrective saccades 
less than 125 ms were not counted as fixations. The program saves the data 
between each set of cursors and stores it in a file for each patient. The 
information obtained from the head and eye data includes velocity, acceleration, 
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position, and time. The program calculates average velocity, sum of squares, 
and duration of fixation and number of points within each fixation. VfPlot 
calculates the velocity at each point using a 2-point central difference method. 
This method uses information from the surrounding points to calculate the value 
for each point, and is unique because it provides an accurate measure of velocity 
and suppresses noise through a low pass filter [361. 
The VfPlot program saves the data obtained between the cursors in an 
ANSI1 file which is opened in Microsoft ExcelTM for editing and extraction of data. 
The data obtained were analyzed for eye and head position and for the number 
and duration of fixations, saccadic amplitude and duration, and velocity. These 
data values were compared to the data of the controls. They were statistically 
analyzed for differences in average absolute velocity of movement during 
fixations between the patients and controls. The absolute velocity of the eye 
movement was chosen as a measurement to show instabilities in the eyes. 
Because some movements were positive and some negative, the velocities of 
these movements would cancel each other if the average of them was taken. To 
account for this, the absolute velocity was used to show the true movement of 
the eye. The data was analyzed to determine any correlation between groups 
and/or UPDRS ratings. The data were analyzed using the JMPTM statistical 
software. 
CHAPTER 3 Results 
Observational differences between the eye movements of the PD patients 
and the controls were seen during initial inspection of the eye movement data 
(Figures 8 and 9). The head data was inspected and showed no signs of 
movement and/or tremor, so the gaze was not affected by head movement and is 
due to eye position. The control group data followed very predictable patterns 
and movements, while the PD data did not. The eye movements in the PD data 
appeared to be unstable because the recordings were not as straight and 
predictable as the control group data. As described in the literature, an 
increased number of fixations in the PD group were observed. The PD patients 
required more saccades to get to the desired target position. 
The three recordings below show recordings of eye movements during the 
simple fixation tasks. These are a representative sample of the typical, stable 
fixations seen in the control group. The third recording is from an 85 year old 
man. While saccadic intrusion can be seen, the fixations are stable, providing 
further evidence of the age effects of the visual system. 
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Figure 8: Sample recordings of eye positions for 
Control group 
The following five recordings are a representative sample of those 
recorded from the PD group. They are showing individuals with increasing 
UPDRS scores and show mildly unstable fixations to more severe unstable 
fixations, to continual nystagmus that may or may not affect eye movements in 
both eyes. 
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Positional data was briefly analyzed to determine how useful it would be 
in determining instabilities of eye movements. The largest range of eye 
movements instructed in the fixation task was &20°. Figure 10 shows the 
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positional data for both the control group and the PD group. The data was 
predicted to be clumped around the axis at 0, &5", &1O0, f l5",  and &20°. The 
actual positional data did not behave in this way. While there are concentrated 
values along the horizontal and vertical axis, there are many positional data 
well outside the instructed range. The figure also shows the saturation of the 
device. Figure 11 shows the same data restricted to those positions less than 
Positional Data 
Mean Horizontal Position 
(deg) 
Control PD 
Figure 10: Positional data for control group and PD group. 
Positional Data (Mean <30 deg) 
pi- w * 
Mean Horizontal Position (deg) 
rn Control r r  
Figure 1 I: Positional data restricted to positions less than 30". 
The average number of points per fixation was higher in the control 
group than the PD group (Table 1) in both the horizontal and vertical directions. 
This may support the observation that PD patients require more saccades to 
accomplish the same visual task. Given a time frame, if they are making more 
saccades to get to a target, there is less time to spend fixating on the actual 
target. Because the subjects are instructed verbally when to fixate on each 
target dot, there may be some small differences in how long they were given to 
fixate before the investigator called out the next target. While the average 
absolute velocities are higher in the vertical direction in both the CTL and PD 
groups, the average number of points per fixation does not vary with direction 
of eye movement. 
Direction 
CTL I Horizontal I 2763 
I PD I Horizontal I 7754 1 557759 1 72 I 
Total # of 
Fixations 
CTL 
221 786 
the CTL group in both the horizontal and vertical direciions. 
Total # of 
Points 
80 
I I 
Vertical 
PD 
Preliminary analysis of the PD data showed a high degree of skewness as 
compared to the control group (Figures 12 and 13). Because of this, parametric 
methods of statistical analysis could not be used to analyze the data. The data 
also did not meet the assumptions of non-parametric tests, so to correct for this, 
both the PD and control group data were normalized using a logarithmic 
transformation. A repeated-measures-mixed-model ANOVA test was then used 
to determine any significant differences between the average absolute velocity 
during fixations between the patient and control groups. 
Avg # of points per 
fixation 
I 
2841 
Table 1: The average number or points per fixation is greater in 
Vertical 
228782 ' 
7772 
81 
559786 72 
Histogram for Control Group (Horizontal) 
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30. - 
22. - 
15. - 
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7.  - 
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Mean Absolute Velocity ("Is) 
Histogram for PD group (Horizontal) 
Mean Absolute Velocitv ("Is) 
Box Plot 
Figure 12: Distributions of 
Mean Absolute Velocity of 
eye movements in the 
horizontal direction during 
fixation for Controls and PD 
patients. 
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Amount 
5.00 - 
0.00 L-2- Controls Variables PD 
Figure 13: Distributions of 
Mean Absolute Velocity of 
eye movements in the 
vertical direction during 
fixation for Controls and PD 
patients. 
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The absolute velocities of the fixational eye movements were greater in 
the vertical direction in both the PD and control groups, and the standard 
deviations of the movements were also greater in the vertical direction in both 
groups (Figure 14 and Table 2), Instabilities within fixations were observed for a 
majority of the PD patients, while only few were seen in controls. These 
differences were measured using the repeated-measures-mixed-model ANOVA 
test. This test showed statistically significant (0.05 level) differences of the 
average absolute velocity of eye movement during fixations and the standard 
deviations between the PD patients and the controls in both the horizontal and 
vertical directions (Table 2). 
o 2 4 6 a 10 
Mean Absolute Velocity ( ' Is)  
o CTL - PD 
A Means 
Figure 14: Scatter plot showing standard deviation of absolute velocity vs mean 
absolute velocity. This figure shows the overlap between CTL and PD velocities, 
but also shows that the PD group means are higher. 
Veloc i ty  
Gro u or ientat ion y 
CTL horizonta I 1 . 4 2 5  1  .I 8 6  1 . 7 1 2  
ve rtic a  I 1 . 7 0 2  1 . 4 1 7  2 . 0 4 5  
P D  h c  rizo nta I 1 . 9 4  0  1 . 6 9 7  2 . 2  17 
vertic a l  2 .1  8 6  1 . 9 1  2  2 . 4 9 8  
S D  Ve loc i ty  
g M e a n  9 5 %  C I  
C TL h  o rizo nta I 1 . 9 5 2  1 . 7 0 2  2 . 2  38 
ver t i ca l  2 .O 9  9  1 . 8 3 1  2 . 4  06  
PD hor izonta l  2 . 4  8  5 2 . 2 4 9  2 . 7 4 5  
ver t i ca l  2 . 5 5 6  2 . 3 1 4  2 . 8  23  
Table 2: The geometric means (gMean, "Is) are the result of transforming 
back from the logarithmic values of the absolute velocities and standard 
deviations during fixation used during the statistical analysis. The 
gMean differences between the PD and Control (CTL) groups are 
significant at the 95% CI. 
Before recording, notes about certain characteristics were taken on the 
subject. Table 3 shows those patients who are DBS patients, as well as those 
who are not on any PD medication. Those that complained of visual problems 
are also listed. The average absolute velocity of eye movement was 
calculated for each subgroup; patients not on any PD medication, patients 
with DBS, and patients who complained of visual problems or problems 
reading. While the average velocities were higher than the PD group in all but 
one subgroup (visual problems-vertical), there were only two that were found to 
be significantly different. Patients with DBS had a average velocity significantly 
lower than those of the whole PD group (in the vertical direction), and patients 
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who complained of visual problems had a significantly higher average velocity 
than those of the whole PD group (in the horizontal direction). 
Subiect # Notes I 
PD 4 
PD 5 
PD 7 
PD 19 
without meds 
recent DBS, just adjusted 
bilateral DBS, visual problems during reading 
bilateral DBS, complaints of visual problems 
PD 29 no longer reading (former attorneyj 
PD 36 
PD 39 
PD 41 
PD 42 
PD 44 
DBS just adjusted 
problem with reading 
no meds, PD for -1 yr 
occasional bluriness 
complaints of vision problems 
PD 47 
PD 49 
PD 50 
PD 51 
no complaints of vision, but no longer reads 
difficulty reading 
difficulty with reading, bluriness 
No PD meds, hasn't started the meds yet 
PD 52 
PD 53 
PD 61 
I I 
Table 3: Notes about some of the PD patients that were taken before 
recording. 
no PD meds, diagnosed -1 yr ago 
DBS patient, recorded after adjustment 
com~lained of visual difficultv 
PD 64 
PD 66 
I Group Orientation 1 gMean ( O J S )  I meds 1 DBS 1 Visual Problems 
no PD meds 
bilateral DBS 
I CTL horizontal 1.425 1 - 1  
1 1 vertical 1.702 
I PD horizontal 1 1.940 1 2.159 1 1.801 1 2.390* 
* indicates significant difference 
- 
1 vertical 
Table 4: Comparison of gMeans between individual groups. 
2.186 2.043 1 1.787' 1 2.140 
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A linear regression model was used to determine if there was a correlation 
between the absolute velocity during fixation and disease severity, as measured 
by the UPDRS rating. The tests did not show significance in the correlation for 
either direction, however there was a higher degree of correlation in the 
horizontal direction than in the vertical (Figures 15 and 16). The critical 
correlation coefficient is 0.2787, p = 0.05 level with 48 dof. The regression 
coefficient in the horizontal direction is equal to 0.2077, and the critical 
correlation coefficient in the vertical direction is equal to 0.005. 
Correlation of Horizontal Absolute Velocity and UPDRS 
o . o l l l l l l , l l l l l l l l l , l l l l  
0.0 15.0 30.0 45.0 60.0 
UPDRS 
Figure 15: Correlation of Horizontal Absolute Velocity during Fixation and 
Clinical Measure (UPDRS). 
Correlation of Vertical Absolute Velocity and UPDRS 
Figure 16: Correlation of Vertical Absolute Velocity during Fixation and 
Clinical Measure (UPDRS). 
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CHAPTER 4 Discussion 
Parkinson's patients were found to have unstable eye movements during 
fixation. Because the ability to stabilize fixations is necessary in acquiring visual 
information, this can lead to a decrease in quality of life, as it impacts their ability 
to see clearly, including reading and watching television. This study supports 
results from other studies that there are effects on the visual system from PD. 
Eye movements can be analyzed in different ways, but a popular method 
is using algorithms to determine where saccades, fixations, or compensatory 
movements are located in the data. This is not possible with the eye movement 
data for the PD patients. Even in the simple fixation tasks, their eye movements 
are very unpredictable and do not follow any set pattern. Some of the analysis 
becomes subjective as one tries to determine where the patient is looking and 
when are they fixating. While it is important to have criteria in identifying 
fixations, it may be more difficult in .the PD data to identify fixations using only 
those criteria. 
Initial observation of the eye movement recordings showed drama.tic 
differences between the controls and the PD patients. The control group 
recordings tended to appear very stable, with "clean" lines and easily identifiable 
fixations. The PD data was less stable, with some data appearing difficult to 
identify fixations. The recordings had many small, non-rhythmic instabilities, 
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sometimes appearing as a very noisy signal. There were several PD recodings 
in which rhythmic oscillations (nystagmus) was identified. These patients tended 
to be further along in the progression of the disease. Other observations showed 
.that PD patients made more fixations than the control groups to accomplish the 
same task, and the average length of fixations were longer in the CTL group as 
compared to the PD. 
Methods for comparing instability in the fixational eye movements can 
include using eye position, velocity, and standard deviations of these. Positional 
data can be affected by individual differences between subjects, but the standard 
deviation of position can give insight into instability of the eye movements. One 
study showed that there was an increased standard deviation of position in 
patients with PD when compared to age-matched controls [341. This supports the 
findings in this study that there is an increase of instability in eye movements of 
PD patients. Because of the limitations of positional data, velocity of the eye 
movements, as well as the standard deviation of the velocity, was used in this 
study. This allows for detection of additional movements in the eyes of PD 
patients that can give insight into the instabilities seen in these patients. 
The distributions of the absolute velocity in both the horizontal and vertical 
directions were highly skewed for the PD data, but it was normal for the control 
group, demonstrating the irregularity of the PD data. The standard deviations of 
the PD data were also highly skewed. The logarithmic transformation values of 
the original data were used in the statistical analysis to normalize the data. The 
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repeated-measures-mixed-model ANOVA accounts for the repeated number of 
fixations within each subject. The lengths of fixation were weighted in the 
analysis, but when not weighted, the same trends occurred. The results of the 
ANOVA test showed that there were significant differences in the geometric 
/ 
means between the patients and controls in both the horizontal and vertical 
directions. The results show (Figure 12) that there is some overlap in mean 
values between the control group and the PD group; however the PD group 
means are significantly higher. These results are significant because they show 
that Parkinson's disease does have an effect on fixational stability 
A linear regression was performed to determine the correlation between 
the absolute velocity of eye movements and the clinical measure, UPDRS. A 
significant correlation would demonstrate the opportunity to use eye movements 
as an objective measure of disease progression. The correlation was not 
significant in either direction; however, there was a disparity between the levels 
of correlation between the two directions. The correlation in the horizontal 
direction was very close to the significant level, while in the vertical direction, the 
two measures were found to be independent with almost not correlation. 
The reasons for this difference are unknown, but it may be affected by the 
limited vertical movements seen in normal older patients as well as those with 
Parkinson's disease. Research shows vertical eye movements become 
restricted with but horizontal eye movements do not. Age effects may be 
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affecting the correlation between the velocity of the eye movements and the 
UPDRS scores. 
Medication may have had a large impact on the result of this study. The 
subjects were not required to stop their medications for ,this study, nor were they 
required to be tested during only "on" or "off" times during their medication cycle. 
This may affect the study in several ways. While there were significant 
differences between the absolute velocities of eye movements during fixation of 
controls and patients, more significant differences may be found if the patients 
were off of their medications. Medication may have also effected the correlation 
of the velocity to the UPDRS. The correlation of the UPDRS rating and the 
absolute velocity of eye movements during fixation were not found to be 
significant, although a relationship can be seen. An accurate assessment of this 
correlation would require the patients to be not only clinically evaluated, but also 
tested without medications. Assuming that the medications are helping the 
symptoms, the UPDRS ratings may be lower on the medication than without. 
Another way to test for this correlation would be to run the study on a large 
number of patients with deep brain stimulators (DBS). These patients can easily 
turn on and off the device and can be assessed clinically and participate in the 
study with the device on and off. As seen in Table 3, the mean absolute velocity 
of the known DBS patients was significantly lower (in the vertical direction) than 
the mean of the whole PD group. 
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This study could be improved in several ways. The sequence in which the 
subjects are instructed to fixate on the target dots should be standardized. This 
would allow for easier graphical comparisons, as well as statistical analysis of 
comparative positional data. The subjects, as well as controls, can be tested 
multiple times over time, to record their results as the disease progresses. As 
stated above, using DBS patients can be beneficial because eye movement data 
can be recorded without the influence of PD medication. Testing the DBS 
patients while "on" and "off" could also show what affect the DBS, and possibly 
medications, may have on the stability of eye movements in the patients. 
Another method for improving this study would be to measure the eye 
movements or both eyes. Measuring the eye movements monocularly may be 
customary in eye movement studies due to the normal behavior of eye acting in 
synchronization with each other; however, because of the unusual eye 
movements seen in these PD patients, it may not be a valid assumption that the 
left eye is doing the same things as the right. This is particularly true with PD 
patients because PD begins unilaterally and progresses to become bilateral. It 
would follow that if a patient is only showing symptoms of the left side and we are 
measuring the right eye, that there should be no effects of PD in their eye 
movements. This however, is not what was seen in the results. This may 
strengthen the hypothesis that the instabilities in the eye movements precede 
outward tremor in the limbs. 
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Another aspect not addressed in this study is the effect of position angle 
on the stability of the eyes. The stability of eye movements at 0 compared to +5", 
+10°, +15", +20°, etc., was not examined in this study, but it is known that the 
eyes become less stable at large angles in either direction. Further research can 
compare the stability of the eyes at different distances in PD patients and 
compare that controls. 
Future research can include the use of accelerometers to measure body 
tremor during the study so that the data can be correlated with the eye data 
obtained. The sub-sections of the UPDRS Motor section (Ill) can also be 
correlated to the data individually to determine if certain sub-sections are highly 
correlated to the fixation data. Another way to compare the data would be to 
include a standard questionnaire as part of the study to evaluate patient's 
complaints, such as problems reading, watching television, and problems with 
blurriness. This qualitative analysis of their complaints can be grouped and 
compared to their eye movement data to determine any correlation. 
The future of this research lies in several areas. If these unstable eye 
movements preceded visual signs of tremor in other parts of the body, as seen in 
this study, this simple visual test can be used for early detection of Parkinson's 
disease. It may also be used as a more objective clinical measure of the 
progression of the disease. These results can also lead to further research into 
medications including treatment for these fixation instabilities. This can also lead 
to improvements in DBS technology that can allow for treatment of these visual 
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instabilities as well. These improvements can lead to a better quality of life for 
PD patients. 
CHAPTER 5 Conclusions 
In order to extract visual information, it is critical,to have the ability to 
stabilize fixation and gaze. If the fixation is unstable, the images can be smeared 
on the retina causing a loss of acuity and contrast sensitivity. Studies are 
beginning to show that fixational stability is compromised in patients with 
Parkinson's disease. This can lower the quality of life for these patients. Further 
research into this area may lead to medication that can help stabilize fixation for 
these patients. It is first crucial to understand what affect the disease is having 
on the patients and the magnitude of what losing fixational stability means to 
them. 
A large amount of information acquired is through the visual system. A 
deficit in this system can have profound effects on the patients' lives. Patients 
can lose the ability to read, drive, watch television, or even see other people 
clearly. Because the ability to stabilize fixation and gaze is so important in 
acquiring information, more research needs to be done to better understand the 
how Parkinson's disease affects the visual system. 
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Appendices 
APPENDIX A 
I Avg ABSVelocity I Std Dev. 
CTL 34 
CTL 35 
CTL 36 
MAX 85 
MIN 58 
AVG 71.8 
Control data divided by subject 
2.332 
5.985 
2.136 
85 
77 
M 
M 
M 
V A 
V A 
V A 
1.944 
3.261 
1.533 
2.155 
3.470 
1.343 
3.258 
4.240 
1.955 
APPENDIX B 
Avg ABSVelocity 
( O h )  
Std Dev. 
MAX 84 
MIN 52 
AVG 71.5 
PD data divided by subject 
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